Corinne Epperly

U.S. Chief Operating Officer
VBL Therapeutics
Israel

Biography

  She also earned a Distinguished B.A. from the University of Virginia where she studied biochemistry and biology. Prior to medical school she conducted biomedical research in Experimental Immunology on checkpoint inhibition and tumor suppressor genes in the National Cancer Institute, National Institutes of Health.

Research Intrest

  Dr. Epperly joined VBL in 2017 and is an oncology expert with deep U.S. experience in drug development, strategy, commercialization and operations. Prior to joining VBL, she spent seven years at Bristol-Myers Squibb (BMS), where she delivered results across diverse roles spanning marketing, M&A, strategic operations and medical strategy in the U.S. Immuno-Oncology Business. 

Global Scientific Words in Clinical Sciences